NCT03201445Phase 2Terminated

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease

Study sponsor: Lakefront Biotherapeutics NV · LKFT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-11-20Actual
Enrollment · participants139Actual
Source updated2024-10-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview